BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 33379176)

  • 1. Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion.
    Crivelli JJ; Mitchell T; Knight J; Wood KD; Assimos DG; Holmes RP; Fargue S
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33379176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of gut microbiota against calcium oxalate.
    Sadaf H; Raza SI; Hassan SW
    Microb Pathog; 2017 Aug; 109():287-291. PubMed ID: 28624518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the microbiome in kidney stone formation.
    Mehta M; Goldfarb DS; Nazzal L
    Int J Surg; 2016 Dec; 36(Pt D):607-612. PubMed ID: 27847292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.
    Miller AW; Choy D; Penniston KL; Lange D
    Kidney Int; 2019 Jul; 96(1):180-188. PubMed ID: 31130222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering urinary oxalate excretion to decrease calcium oxalate stone disease.
    Holmes RP; Knight J; Assimos DG
    Urolithiasis; 2016 Feb; 44(1):27-32. PubMed ID: 26614109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S; Alebouyeh M; Naji M; Shakiba Majd G; Shabani Nashtaei M; Broumandnia N; Basiri A
    BJU Int; 2020 Jan; 125(1):133-143. PubMed ID: 31145528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist.
    Daniel SL; Moradi L; Paiste H; Wood KD; Assimos DG; Holmes RP; Nazzal L; Hatch M; Knight J
    Appl Environ Microbiol; 2021 Aug; 87(18):e0054421. PubMed ID: 34190610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers.
    Ticinesi A; Milani C; Guerra A; Allegri F; Lauretani F; Nouvenne A; Mancabelli L; Lugli GA; Turroni F; Duranti S; Mangifesta M; Viappiani A; Ferrario C; Dodi R; Dall'Asta M; Del Rio D; Ventura M; Meschi T
    Gut; 2018 Dec; 67(12):2097-2106. PubMed ID: 29705728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate.
    Troxel SA; Sidhu H; Kaul P; Low RK
    J Endourol; 2003 Apr; 17(3):173-6. PubMed ID: 12803990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium Oxalate Nephrolithiasis and Gut Microbiota: Not just a Gut-Kidney Axis. A Nutritional Perspective.
    Ticinesi A; Nouvenne A; Chiussi G; Castaldo G; Guerra A; Meschi T
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32093202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oxalobacter formigenes--characteristics and role in development of calcium oxalate urolithiasis].
    Torzewska A
    Postepy Hig Med Dosw (Online); 2013 Nov; 67():1144-53. PubMed ID: 24379255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxalate-degrading microorganisms or oxalate-degrading enzymes: which is the future therapy for enzymatic dissolution of calcium-oxalate uroliths in recurrent stone disease?
    Peck AB; Canales BK; Nguyen CQ
    Urolithiasis; 2016 Feb; 44(1):45-50. PubMed ID: 26645869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
    BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion.
    Jiang J; Knight J; Easter LH; Neiberg R; Holmes RP; Assimos DG
    J Urol; 2011 Jul; 186(1):135-9. PubMed ID: 21575973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease.
    Siener R; Bangen U; Sidhu H; Hönow R; von Unruh G; Hesse A
    Kidney Int; 2013 Jun; 83(6):1144-9. PubMed ID: 23536130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal colonization with Oxalobacter formigenes and its relation to urinary oxalate excretion in pediatric patients with idiopathic calcium urolithiasis.
    Sikora P; Niedźwiadek J; Mazur E; Paluch-Oleś J; Zajaczkowska M; Kozioł-Montewka M
    Arch Med Res; 2009 Jul; 40(5):369-73. PubMed ID: 19766900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease.
    Knight J; Deora R; Assimos DG; Holmes RP
    Urolithiasis; 2013 Jun; 41(3):187-96. PubMed ID: 23632911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut-inhabiting bacterium Oxalobacter formigenes: role in calcium oxalate urolithiasis.
    Mittal RD; Kumar R
    J Endourol; 2004 Jun; 18(5):418-24. PubMed ID: 15253809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of dietary patterns with gut microbiota in kidney stone and non-kidney stone individuals.
    Yuan C; Jin X; He Y; Liu Y; Xiang L; Wang K
    Urolithiasis; 2022 Aug; 50(4):389-399. PubMed ID: 35460343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.